Compugen to Present at the SVB Securities Global Biopharma Conference - The Globe and Mail

Retrieved on: 2024-02-25 18:43:10

Tags for this article:

Click the tags to see associated articles and topics

Compugen to Present at the SVB Securities Global Biopharma Conference - The Globe and Mail. View article details on hiswai:

Summary

Compugen Ltd., a biopharma company specializing in cancer immunotherapy, is set to present at the SVB Securities Global Biopharma Conference. This involves Leerink Partners and SVB as stakeholders in the biopharma industry context.

Article found on: www.theglobeandmail.com

View Original Article